Effects of pump versus twice-daily injection delivery of synthetic parathyroid hormone 1-34 in children with severe congenital hypoparathyroidism.

[1]  S. Cremers,et al.  Therapy of hypoparathyroidism with PTH(1-84): a prospective four-year investigation of efficacy and safety. , 2013, The Journal of clinical endocrinology and metabolism.

[2]  Michael Vrla,et al.  Long-term follow-up of patients with hypoparathyroidism. , 2012, The Journal of clinical endocrinology and metabolism.

[3]  L. Rejnmark,et al.  PTH replacement therapy of hypoparathyroidism , 2012, Osteoporosis International.

[4]  P. Albert,et al.  Synthetic human parathyroid hormone 1-34 replacement therapy: a randomized crossover trial comparing pump versus injections in the treatment of chronic hypoparathyroidism. , 2012, The Journal of clinical endocrinology and metabolism.

[5]  L. Rejnmark,et al.  The effect of adding PTH(1–84) to conventional treatment of hypoparathyroidism: A randomized, placebo‐controlled study , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[6]  P. Bougnères,et al.  Long-term results of continuous subcutaneous recombinant PTH (1-34) infusion in children with refractory hypoparathyroidism. , 2011, The Journal of clinical endocrinology and metabolism.

[7]  J. Kornhuber,et al.  Statistical methods for detecting and comparing periodic data and their application to the nycthemeral rhythm of bodily harm: A population based study , 2010, Journal of circadian rhythms.

[8]  J. Reynolds,et al.  Long-term treatment of 12 children with chronic hypoparathyroidism: a randomized trial comparing synthetic human parathyroid hormone 1-34 versus calcitriol and calcium. , 2010, The Journal of clinical endocrinology and metabolism.

[9]  M. Rubin,et al.  Therapy of hypoparathyroidism with intact parathyroid hormone , 2010, Osteoporosis International.

[10]  M. Puig-Domingo,et al.  Successful treatment of vitamin D unresponsive hypoparathyroidism with multipulse subcutaneous infusion of teriparatide. , 2008, European journal of endocrinology.

[11]  N. Sinaii,et al.  Effects of once versus twice-daily parathyroid hormone 1-34 therapy in children with hypoparathyroidism. , 2008, The Journal of clinical endocrinology and metabolism.

[12]  A. F. Stewart,et al.  Hypoparathyroidism: is it time for replacement therapy? , 2008, Journal of Clinical Endocrinology and Metabolism.

[13]  Paul S Albert,et al.  On Analyzing Circadian Rhythms Data Using Nonlinear Mixed Models with Harmonic Terms , 2005, Biometrics.

[14]  J. Brodehl.  Assessment and interpretation of the tubular threshold for phosphate in infants and children , 1994, Pediatric Nephrology.

[15]  A. Krause,et al.  Assessment of maximal tubular phosphate reabsorption: comparison of direct measurement with the nomogram of Bijvoet , 1988, Pediatric Nephrology.

[16]  L. Gerber,et al.  Long-term treatment of hypoparathyroidism: a randomized controlled study comparing parathyroid hormone-(1-34) versus calcitriol and calcium. , 2003, The Journal of clinical endocrinology and metabolism.

[17]  V. Carey,et al.  Mixed-Effects Models in S and S-Plus , 2001 .

[18]  J. Yanovski,et al.  A randomized, cross-over trial of once-daily versus twice-daily parathyroid hormone 1-34 in treatment of hypoparathyroidism. , 1998, The Journal of clinical endocrinology and metabolism.

[19]  J. Yanovski,et al.  Synthetic human parathyroid hormone 1-34 vs calcitriol and calcium in the treatment of hypoparathyroidism. , 1996, JAMA.

[20]  G. Mundy,et al.  Pulsatile secretion of parathyroid hormone in normal young subjects: assessment by deconvolution analysis. , 1993, The Journal of clinical endocrinology and metabolism.

[21]  W. Woloszczuk,et al.  [Initial experiences with substitution treatment of hypoparathyroidism with synthetic human parathyroid hormone]. , 1990, Monatsschrift Kinderheilkunde : Organ der Deutschen Gesellschaft fur Kinderheilkunde.

[22]  W. Stögmann,et al.  Erste erfahrungen in der Substituionsbehandlung des Hypoparathyreoidismus mit Synthetischem Humanen Parathormon , 1990 .

[23]  G. Brabant,et al.  Pulse amplitude and frequency modulation of parathyroid hormone in plasma. , 1989, The Journal of clinical endocrinology and metabolism.

[24]  F. Frisone,et al.  Nephrocalcinosis in children and adolescents: sonographic evaluation during long-term treatment with 1,25-dihydroxycholecalciferol. , 1988, Child nephrology and urology.

[25]  F. Santos,et al.  Hypercalciuria associated with long-term administration of calcitriol (1,25-dihydroxyvitamin D3). Action of hydrochlorothiazide. , 1986, American journal of diseases of children.

[26]  M. Peacock,et al.  Tubular reabsorption of calcium in normal and hypercalciuric subjects , 1968, Journal of clinical pathology.